4 hours ago
6
A major Cochrane review has found that drugs designed to target amyloid beta proteins in the brain are unlikely to provide meaningful benefits for patients. At the same time, these treatments appear to increase the risk of brain swelling and bleeding.
Amyloid beta is a protein that builds up in the brains of people with Alzheimer's disease, often years before symptoms appear. Scientists have long believed that removing these protein deposits could slow or prev...
English (US) ·